-
France threatens Shein ban if 'childlike' sex dolls reappear
-
International cricket returns to Faisalabad with Pakistan-South Africa ODIs
-
Afghan govt says quake kills 20, injures over 500
-
'We're all too rich,' says photo legend Martin Parr
-
Tanzania president inaugurated as opposition says hundreds dead
-
Shafali Verma: India's World Cup hero who disguised herself as boy
-
Most equity markets rise on lingering trader optimism
-
Asian markets rise on lingering trader optimism
-
Afghanistan quake kills 20, injures over 300: health ministry
-
India hails maiden women's World Cup cricket title as game-changer
-
As clock ticks down, Greece tries to clean up its act on waste
-
Local fabrics, fibres shine at eco-centred Lagos Fashion Week
-
Spalletti bidding to revive Juve and reputation ahead of Sporting visit in Champions League
-
Tanzania president to be inaugurated as opposition says hundreds dead
-
Bouanga brace as LAFC beats Austin 4-1 to advance in MLS Cup playoffs
-
'Golden age': Japan hails Yamamoto, Ohtani after Dodgers triumph
-
Thunder roll over Pelicans to remain NBA's lone unbeaten team
-
Hong Kong legislature now an 'echo chamber', four years after shake-up
-
Most Asian markets rise on lingering trader optimism
-
Andrew to lose his last military rank: defence minister
-
Trump's global tariffs to face challenge before Supreme Court
-
Barnstorming Bayern face acid test at reigning champions PSG
-
Alonso shaping new Real Madrid on Liverpool return
-
Half Yours favourite at Australia's 'race that stops a nation'
-
Tonga rugby league star has surgery after 'seizure' against NZ
-
Trent's return with Real Madrid reminds Liverpool of what they are missing
-
Tehran toy museum brings old childhood memories to life
-
Iran banking on Iraq vote to retain regional influence
-
Daughter of 'underground' pastor urges China for his release
-
Trump the Great? President steps up power moves
-
Fire ravages French monastery dubbed 'Notre-Dame of the Ardennes'
-
Bills outlast Chiefs while NFL-best Colts fall to Steelers
-
NBA champion Thunder roll over Pelicans to remain unbeaten
-
Eliud Kipchoge unveils plan to run 7 marathons on 7 continents
-
Milan deny Roma top spot in Serie A, Inter beat Verona
-
Lens back up to third in Ligue 1 as Lyon held at Brest
-
NFL-best Colts fall to Steelers, Packers lose to Carolina
-
'Regretting You' wins spooky slow N. American box office
-
'Just the beginning' as India lift first Women's World Cup
-
Will Still sacked by struggling Southampton
-
Malinin wins Skate Canada crown with stunning free skate
-
Barca beat Elche to recover from Clasico loss
-
Jamaica deaths at 28 as Caribbean reels from colossal hurricane
-
Verma and Sharma power India to first Women's World Cup triumph
-
Auger-Aliassime out of Metz Open despite not yet securing ATP Finals spot
-
Haaland fires Man City up to second in Premier League
-
Sinner says staying world number one 'not only in my hands'
-
Ready for it? Swifties swarm German museum to see Ophelia painting
-
Pope denounces violence in Sudan, renews call for ceasefire
-
Kipruto, Obiri seal Kenyan double at New York Marathon
US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
D.Qudsi--SF-PST